Immunohistochemical Expression of Serine and Arginine-Rich Splicing Factor 1 (SRSF1) in Fluoro-Edenite-Induced Malignant Mesothelioma: A Preliminary Study
Open Access
- 9 June 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (12) , 6249
Abstract
The Serine and Arginine-Rich Splicing Factor 1 (SRSF1) has a proto-oncogenic function, being associated with angiogenesis and frequently overexpressed in many human malignant neoplasms. Its immunohistochemical expression has never been investigated in malignant pleural mesothelioma (MPM). We evaluated SRSF1 immunoexpression and its possible relation to angiogenesis in a selected cohort of 10 fluoro-edenite(FE)-induced MPM cases. Methods: Immunohistochemical analyses with an anti-SRSF1 antibody were performed. We interpreted the cases as positive if tumor cell nuclei were stained; a semi-quantitative analysis of the cases was performed by evaluating the intensity of staining and the percentage of tumor positive cells. A microvessel density (MVD) count was also performed. Results: High and low immunoexpressions of SRSF1 were seen in six and four MPMs, respectively. A trend of shorter overall survival was found in FE-induced MPM patients with SRSF1 overexpression. In addition, a significant association between high-MVD and high SRSF1 immunoexpression (p = 0.0476) was found. Conclusions: SRSF1 appears to be involved in MPM pathogenesis and its immunoexpression may represent a prognostic biomarker capable of identifying subgroups of patients with different prognosis. However, given the preliminary nature of the present study, further investigations on larger series, and additional in vitro studies, are required to validate our findings.Keywords
This publication has 33 references indexed in Scilit:
- Sheep lymph-nodes as a biological indicator of environmental exposure to fluoro-edeniteEnvironmental Research, 2016
- The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 ClassificationJournal of Thoracic Oncology, 2016
- FBLN-3 as a Biomarker of Pleural Plaques in Workers Occupationally Exposed to Carcinogenic Fibers: A Pilot StudyFuture Oncology, 2015
- SRSF1-Regulated Alternative Splicing in Breast CancerMolecular Cell, 2015
- Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2015
- Detection of pleural plaques in workers exposed to inhalation of natural fluoro-edenite fibresOncology Letters, 2015
- Carcinogenicity of fluoro-edenite, silicon carbide fibres and whiskers, and carbon nanotubesThe Lancet Oncology, 2014
- The Role of Intrinsic Pathway in Apoptosis Activation and Progression in Peyronie’s DiseaseBioMed Research International, 2014
- Pleural Mesothelioma Cases in Biancavilla are Related to a New Fluoro-Edenite Fibrous AmphiboleArchives of Environmental Health: An International Journal, 2003
- Unusually High Incidence of Malignant Pleural Mesothelioma in a Town of Eastern Sicily: An Epidemiological and Environmental StudyArchives of Environmental Health: An International Journal, 2000